CAT-5571
/ BioCryst Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 04, 2020
"Catabasis Pharmaceuticals and Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive and Drug-Resistant Tuberculosis https://t.co/XUJM2EoM6K"
(,@NewsFromBW)
Infectious Disease • Tuberculosis
1 to 1
Of
1
Go to page
1